Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Qu, Li Shuai ^a   Liu, Jin Xia ^a   Liu, Tao Tao ^b   Shen, Xi Zhong ^b   Chen, Tao Yang ^c   Ni, Zheng Pin ^c   Lu, Cui Hua ^a  

^a NANTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c QIDONG LIVER CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; HEPATITIS B SURFACE ANTIGEN; START CODON;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; GENE DELETION; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; START CODON; VIRUS MUTATION; COMPLICATION; DISEASE COURSE; GENETICS; GENOTYPE; HEPATITIS B VIRUS; LIVER TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PATHOLOGY; SMOKING; VIROLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; CODON, INITIATOR; COHORT STUDIES; DISEASE PROGRESSION; GENE DELETION; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; SEQUENCE DELETION; SMOKING;

EID: 84901313349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098257     Document Type: Article

References (31)

1. Liaw YF, Chu CM (2009) Hepatitis B virus infection. Lancet;373: 582-92.
2. Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395-403.
3. Chen CJ, Yang HI, Iloeje UH (2009) Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49:S72-84.
4. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-17. (Pubitemid 37518510)
5. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733-45.
6. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-43.
7. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, et al. (2008) HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol 103: 2254-62.
8. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, et al. (2007) Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133: 1466-74. (Pubitemid 350029756)
9. Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, et al. (2006) T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 42: 1-7. (Pubitemid 41832072)
10. Guo X, Jin Y, Qian G, Tu H (2008) Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 49: 718-25.
11. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, et al. (2008) Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57: 98-102.
12. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, et al. (2001) Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33: 277-86.
13. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, et al. (1997) Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26: 495-9. (Pubitemid 27328332)
14. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, et al. (2003) Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70: 537-44. (Pubitemid 36734717)
15. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, et al. (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-68.
16. Kurbanov F, Tanaka Y, Mizokami M (2010) Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res 40: 14-30.
17. Qu L, Kuai X, Liu T, Chen T, Ni Z, et al. (2013) Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China. PLoS One 8:e59583.
18. Qu LS, Liu TT, Jin F, Guo YM, Chen TY, et al. (2011) Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China. Hepatol Res 41: 54-63.
19. Qu LS, Zhu J, Liu TT, Shen XZ, Chen TY, et al. (2014) Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China. Hepatol Res; in press.
20. Mun HS, Lee SA, Jee Y, Kim H, Park JH, et al. (2008) The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol 80: 1189-94. (Pubitemid 351705997)
21. Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, et al. (2003) High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41: 5449-55. (Pubitemid 37543229)
22. Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60.
23. Ferrari C, Cavalli A, Penna A, Valli A, Bertoletti A, et al. (1992) Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. Gastroenterology 103: 255-63.
24. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, et al. (2007) Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14: 161-8.
25. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, et al. (2008) Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 89: 2882-90.
26. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, et al. (2003) Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol163: 2441-9. (Pubitemid 37466485)
27. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, et al. (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023-32.
28. Zhong S, Chan JY, Yeo W, Tam JS, Johnson PJ (1999) Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. J Viral Hepat 6: 195-202. (Pubitemid 29260102)
29. Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, et al. (2002) Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol 68: 50-9.
30. Raimondo G, Costantino L, Caccamo G, Pollicino T, Squadrito G, et al. (2004) Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol 40: 515-9. (Pubitemid 38230855)
31. Chan HL, Tse CH, Mo F, Koh J, Wong VW, et al. (2008) High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 26: 177-82.